Nkarta, Inc.
NASDAQ · us_market
No AI insight generated yet for this ticker.
Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. Its lead product candidate is NKX019, a chimeric antigen receptor-natural killer (CAR NK) targeting the CD19 antigen, which is in Phase 1 clinical trial for the treatment of lupus nephritis; systemic sclerosis; idiopathic inflammatory myopathy; and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, as well as for systemic lupus erythematosus and myasthenia gravis. The company has a research collaboration agreement with CRISPR Therapeutics AG. Nkarta, Inc. was incorporated in 2015 and is based in South San Francisco, California.
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| TwoSigma | quant | 2.05M | $4.32M | 0.00% | Added+110.6% | 2026-03-31 |
| RenTech | quant | 1.73M | $3.66M | 0.01% | Added+1.8% | 2026-03-31 |
| StateStreet | passive | 1.24M | $2.61M | 0.00% | Added+5.8% | 2026-03-31 |
| DEShaw | quant | 356.9K | $753.13K | 0.00% | Added+94.7% | 2026-03-31 |
| FidelityFMR | fundamental | 129.1K | $272.40K | 0.00% | Added+7.9% | 2026-03-31 |
| Citadel | multi-strat | 60.3K | $127.33K | 0.00% | Added+9.4% | 2026-03-31 |
| TRowePrice | fundamental | 28.9K | $62 | 0.00% | Unchanged | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-12upcoming | -0.37 | — | — |
| 2026-03-25 | -0.29 | -0.37 | -25.42% |
| 2025-11-10 | -0.30 | -0.29 | +4.39% |
| 2025-08-12 | -0.35 | -0.31 | +11.43% |
| 2025-05-14 | -0.45 | -0.43 | +4.44% |
| 2025-03-26 | -0.41 | -0.35 | +15.23% |
| 2024-11-07 | -0.36 | -0.39 | -9.09% |
| 2024-08-13 | -0.51 | -0.34 | +33.98% |
| 2024-05-09 | -0.56 | -0.58 | -3.94% |
| 2024-03-21 | -0.54 | -0.57 | -5.56% |
| 2023-11-09 | -0.65 | -0.52 | +20.49% |
| 2023-08-10 | -0.68 | -0.68 | +0.58% |
| 2023-05-11 | -0.70 | -0.63 | +10.00% |
| 2023-03-16 | -0.63 | -0.67 | -5.72% |
| 2022-11-09 | -0.62 | -0.58 | +6.24% |
| 2022-08-11 | -0.59 | -0.61 | -2.52% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| NKTX | +10.92% | +26.46% | +75.68% | +86.78% |
| XLV | +2.97% | -4.64% | -3.44% | +12.69% |
| Alpha (stock − sector) | +7.95% | +31.10% | +79.12% | +74.09% |